Fundraising Fox

Cassidy Blundell

Investor

Partner at Mission Biocapital · Board director at Progentos Therapeutics · Board director at Mediar Therapeutics

Cambridge, Massachusetts

Writes $500K checks · typically $1.5M

About

Cassidy Blundell, PhD (UPenn HHMI Interfaces), is a builder-investor whose placental organ-on-chip research informs her interim operational roles at very early-stage biotech startups and represents a fund on multiple boards.

Contact· self-published, not guessed

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Board director at Progentos Therapeutics

Intro paths

In turn, Cassidy can intro founders to Progentos Therapeutics's investors below.

Board director at Mediar Therapeutics

Intro paths

In turn, Cassidy can intro founders to Mediar Therapeutics's investors below.

Experience

  1. Mission BioCapitalPartnercurrent2024 — presentCambridge, Massachusetts, United States
  2. Mission BioCapitalPrincipal2021 — 2024
  3. Mission BioCapitalAssociate2019 — 2021
  4. Mission BioCapitalAnalyst2018 — 2019
  5. University of PennsylvaniaBioengineering PhD Student2012 — 2018Philadelphia, Pennsylvania, United States
  6. Flagship PioneeringVentureLabs Fellow2017Cambridge, Massachusetts, United States
  7. Firefly BioworksBioassay Scientist2011

Skills & more

Immunofluorescence3Biomedical Engineering7Cell Culture2Microfluidics1Research4SolidWorks1Matlab1LabVIEWPolymerase Chain Reaction (PCR)MicroscopyMicrosoft Excel1Data Analysis1
+1 moreMolecular Biology

From Cassidy's professional profile.

Investments

Per SEC Form D filings.

Colleagues at Mission Biocapital

Network5

Investors connected to Cassidy in public investor directories — a warm-intro map.

Frequently asked questions

Who is Cassidy Blundell?
Cassidy Blundell, PhD (UPenn HHMI Interfaces), is a builder-investor whose placental organ-on-chip research informs her interim operational roles at very early-stage biotech startups and represents a fund on multiple boards.
Where does Cassidy Blundell work?
Cassidy Blundell is Partner at Mission Biocapital and Board director at Progentos Therapeutics and Board director at Mediar Therapeutics.
What does Cassidy Blundell invest in?
Cassidy Blundell invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
What check size does Cassidy Blundell write?
Cassidy Blundell typically writes checks of $500K.
What boards does Cassidy Blundell sit on?
Cassidy Blundell holds tracked board seats at Mediar Therapeutics, Progentos Therapeutics.
Where did Cassidy Blundell go to school?
Cassidy Blundell studied at University of Pennsylvania (Doctor of Philosophy (PhD), Bioengineering); Boston University (B.S., Biomedical Engineering).

Same school

Shared employers